What is the NTLA stock price prediction for next 2 weeks?

According to our price prediction algorithm,Intellia Therapeutics, Inc. (NTLA) price will be around $10.58 in the next 2 weeks. This means it will increase by 1.9287090558766744 from the last closing price. This prediction may vary from other time period filters for NTLA stock.

What can be the highest Possible price of NTLA stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, NTLA can achieve the highest price of $10.98 which is 5.8000948022062015 higher than last closing price. This prediction may vary from other time period filters for NTLA stock.

What can be the lowest Possible price of NTLA stock in next 2 weeks?

As per the forecast and algorithmic analysis, NTLA stock price can be as low as $10.16 which is -2.080856332236738 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for NTLA stock.

Will NTLA stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that NTLA stock will gain1.9287090558766744 in the next 2 weeks. This prediction may vary from other time period filters for NTLA stock.

What is NTLA stock last closing price?

Last closing price of NTLA stock was $10.38.

What is NTLA stock price prediction?

NTLA stock price prediction means predicting the future closing prices of NTLA stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of NTLA stock in a certain time period.

How we predict NTLA stock future prices?

If you are searching for NTLA stock forecast, analysis or price prediction, then you might be wondering what Intellia Therapeutics, Inc. (NTLA) will do in the future. Our NTLA price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This NTLA price prediction will likely answer most of your questions.

How frequent we update NTLA stock predictions?

We are updating the forecasts for the NTLA stock on daily basis.

Is using ML forecasting for NTLA stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for NTLA stock same for all the time periods?

No, the prediction for NTLA stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Intellia Therapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$10.389.96%Since 2 Weeks

Predicted Price$10.581.93%For 2 Weeks

Upper Predicted Price$10.985.8%For 2 Weeks

Lower Predicted Price$10.16-2.08%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of NTLA will rise by +1.93% over the next 2 Weeks and hit $10.58 by Friday, January 23, 2026. In that time frame, NTLA's share price is expected to range between $10.16 and $10.98.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jan 23, 2026	10.25	10.68	11.14
Jan 22, 2026	10.66	11.07	11.46
Jan 21, 2026	10.17	10.60	11.00
Jan 20, 2026	10.05	10.48	10.90
Jan 19, 2026	10.07	10.49	10.92
Jan 16, 2026	10.14	10.53	10.95
Jan 15, 2026	10.48	10.91	11.35
Jan 14, 2026	10.00	10.44	10.89
Jan 13, 2026	9.88	10.33	10.77
Jan 12, 2026	9.90	10.34	10.75

NTLA shares fell -1.38% in Friday, January 9, 2026's trading session, dropping from a previous close of $10.52 to move at $10.38. The stock demonstrated notable intraday movement (see NTLA's key stats for a full breakdown), fluctuating between $10.14 and $10.98, a +8.32% trading range. While recent weeks have seen some volatility, NTLA has managed to secure a +9.90% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 6.85M shares changing hands, 156.3K more than the previous session. This amounted to $71.02M in total market activity.

Will NTLA Continue Its Upward Trend?

According to analyst ratings and projections for NTLA, Intellia Therapeutics, Inc. shares are anticipated to increase by +6.90%, potentially reaching $11.14 per share by January 23, 2026. Short-term technical indicators currently suggest a neutral sentiment for NTLA. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the NTLA stock forecast, now is a good time to buy NTLA stock because its current trading price is -2.90% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on NTLA covering social and institutional perspectives.

NTLA Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into NTLA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 50.93% to 67.83%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 47.54%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 48.16%, maintains a neutral outlook for the long term. Insights into NTLA's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Intellia Therapeutics Short-Term Forecasts

NTLA Forecast For Next 5 Days

Our algorithm anticipates Intellia Therapeutics (NTLA) stock could hit $8.52 by Jan 08, 2026. This represents a -17.83% rise from today's price, following a +17.02% change over the past five days.

NTLA Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Intellia Therapeutics, Inc. (NTLA) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $6.51, which would mean a -37.25% decrease from the current price of $10.38. Projections for this period range from a high of $12.62 to a low of $0.29.

NTLA Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Intellia Therapeutics's price over the next three months point to a rise. NTLA stock is expected to peak at $16.44 on Mar 17, 2026 before potentially dipping to $5.95 on Apr 10, 2026. On average, NTLA is likely to trade around $10.84 in the coming 90 days.

Intellia Therapeutics Stock Forecast 2025

Based on our predictive models, Intellia Therapeutics (NTLA) is expected to trade between $4.83 and $35.57 throughout 2026. This would result in an average price of $17.03, potentially offering investors a +64.14% return from current levels.

Intellia Therapeutics, Inc. Monthly Forecast 2026

January 2026

According to our latest forecast models, Intellia Therapeutics, Inc. (NTLA) is positioned to show a strong performance in January 2026. The price is predicted to move between $7.03 and $12.43, settling at an average of $9.58. This could translate to a -7.66% loss.

February 2026

Based on current market signals, Intellia Therapeutics, Inc. is projected to trend february 2026. We forecast a trading range from $6.72 to $13.31, with a likely average price of $9.28. Investors could expect a potential return of -10.55%.

March 2026

Our predictive algorithms indicate Intellia Therapeutics, Inc. stock may see a shift in March 2026. The expected range spans $10.45–$16.44, with an average target of $14.28. This represents a positive outlook and a possible gain of +37.64%.

April 2026

Analyzing established trends, Intellia Therapeutics, Inc. looks set to move in April 2026. Projections place the stock between $4.83 and $11.89, averaging around $7.84. This suggests a -24.43% loss from current levels.

May 2026

Market indicators suggest Intellia Therapeutics, Inc. could experience notable changes during May 2026. Prices could fluctuate within $8.05 to $19.34, with a midpoint forecast of $15.17. The stock might deliver a +46.22% gain.

June 2026

Forecasting for June 2026, models estimate that Intellia Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $11.60 and $19.08, averaging $16.26. This signals a positive trajectory with potential returns around +56.72%.

July 2026

According to our latest forecast models, Intellia Therapeutics, Inc. (NTLA) is positioned to show a strong performance in July 2026. The price is predicted to move between $11.14 and $27.67, settling at an average of $18.57. This could translate to a +78.99% gain.

August 2026

Based on current market signals, Intellia Therapeutics, Inc. is projected to trend august 2026. We forecast a trading range from $17.84 to $29.31, with a likely average price of $25.62. Investors could expect a potential return of +146.94%.

September 2026

Our predictive algorithms indicate Intellia Therapeutics, Inc. stock may see a shift in September 2026. The expected range spans $14.47–$28.02, with an average target of $22.34. This represents a positive outlook and a possible gain of +115.33%.

October 2026

Analyzing established trends, Intellia Therapeutics, Inc. looks set to move in October 2026. Projections place the stock between $15.44 and $35.57, averaging around $27.78. This suggests a +167.76% gain from current levels.

November 2026

Market indicators suggest Intellia Therapeutics, Inc. could experience notable changes during November 2026. Prices could fluctuate within $8.61 to $30.08, with a midpoint forecast of $19.97. The stock might deliver a +92.48% gain.

December 2026

Forecasting for December 2026, models estimate that Intellia Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $7.87 and $28.43, averaging $16.98. This signals a positive trajectory with potential returns around +63.66%.

NTLA's history of dividends and stock splits also plays a role in long-term investor confidence.